Failure of the MicroScan WalkAway system to detect heteroresistance to carbapenems in a patient with Enterobacter aerogenes bacteremia

Journal of Clinical Microbiology

Volumn 47, Issue 9, 2009, Pages 3024-3025

  Gordon, N C ^a   Wareham, D W ^a,b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; ERTAPENEM; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; AUTOMATION; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENTEROBACTER AEROGENES; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; AUTOMATION; BACTEREMIA; BETA-LACTAM RESISTANCE; CARBAPENEMS; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTIONS; FALSE NEGATIVE REACTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

ENTEROBACTER AEROGENES;

EID: 69949107822     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01033-09     Document Type: Article

References (13)

1. Andrews, J. M. 2008. BSAC standardized disc susceptibility testing method (version 7). BSAC Working Party on Susceptibility Testing. J. Antimicrob. Chemother. 62:256-278.
2. Chen, Y. G., Y. Zhang, Y. S. Yu, T. T. Qu, Z. Q. Wei, P. Shen, and L. J. Li. 2008. In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple β-lactamases. Int. J. Antimicrob. Agents 32:302-307.
3. Doumith, M., M. J. Ellington, D. M. Livermore, and N. Woodford. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63:659-667.
4. Harbarth, S., V. Nobre, and D. Pittet. 2007. Does antibiotic selection impact patient outcome? Clin. Infect. Dis. 44:87-93.
5. Jacoby, G. A. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22:161-182.
6. Juretschko, S., V. LaBombardi, S. Lerner, P. Schreckenberger, and the Pseudomonas AST Study Group. 2007. Accuracies of β-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan Walkaway, Vitek, and Vitek 2). J. Clin. Microbiol. 45:1339-1342.
7. Kulah, C., E. Aktas, F. Comert, N. Ozlu, I. Akyar, and H. Ankarali. 2009. Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, MicroScan WalkAway, Vitek 2); high error rates with Microscan WalkAway. BMC Infect. Dis. 9:30.
8. Li, J., C. R. Rayner, R. L. Nation, R. J. Owen, D. Spelman, K. E. Tan, and L. Liolios. 2006. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:2946-2950.
9. Plipat, N., G. Livni, H. Bertram, and R. B. Thomson, Jr. 2005. Unstable vancomycin heteroresistance is common among clinical isolates of methicillin- resistant Staphylococcus aureus. J. Clin. Microbiol. 43:2494-2496.
10. Pournaras, S., A. Ikonomidis, A. Markogiannakis, N. Spanakis, A. Maniatis, and A. Tsakris. 2007. Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J. Med. Microbiol. 56:66-70.
11. Samra, Z., J. Bahar, L. Madar-Shapiro, N. Aziz, S. Israel, and J. Bishara. 2008. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J. Clin. Microbiol. 6:3110-3111.
12. Tenover, F. C., R. K. Kalsi, P. P. Williams, R. B. Carey, S. Stocker, D. Lonsway, J. K. Rasheed, J. W. Biddle, J. E. McGowan Jr., and B. Hanna. 2006. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis. 12:1209-1213.
13. Woodford, N., J. Zhang, M. Warner, M. E. Kaufmann, J. Matos, A. Macdonald, D. Brudney, D. Sompolinsky, S. Navon-Venezia, and D. M. Livermore. 2008. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J. Antimicrob. Chemother. 62:1261-1264.